Research Article

Subclinical seizures on EEG with sleep phases and clinical significance in patients with focal epilepsy

Volume: 18 Number: 2 April 1, 2025
TR EN

Subclinical seizures on EEG with sleep phases and clinical significance in patients with focal epilepsy

Abstract

Purpose: Studies have observed that subclinical seizures significantly impact diagnosis, prognosis, and treatment responses. The aim of our study is to investigate the presence of these seizures, their relationship with sleep, their contribution to diagnosis, and their impact on treatment selection and prognosis in patients diagnosed with partial epilepsy. Materials and methods: A total of 1.626 EEGs conducted in the EEG unit were examined. Among them, 626 were found to belong to patients diagnosed with partial epilepsy. 140 patients who underwent twenty-minute EEG monitoring and 28 patients who underwent twenty-four-hour EEG monitoring were included in the study. Results: A comparative analysis was conducted between two cohorts of patients: one subjected to a twenty-minute EEG and the other undergoing a 24-hour EEG. In the presence of resistant epilepsy, the risk of SCS is increased by 3.1 times. The presence of SCS in frontal lobe epilepsies demonstrated a 2.2-fold elevation compared to temporal lobe epilepsies (1.0-5.3). A statistically significant relationship between Levetiracetam usage and seizures was observed (p=0.044). The calculated Odds Ratio for risk indicated a 1.2-fold (1-1.6) higher frequency of seizures with Levetiracetam usage. Risk analysis revealed a 1.5-fold (1.2-1.9) higher incidence of seizures with the use of well-known drugs in favor of lacosamide-zonisamide. Conclusion: SCSs are gaining increasing clinical significance in terms of diagnosis, prognosis, and treatment. The relationship between these periods of sleep and SCSs is important for future research with a larger number of patients and medical professionals.

Keywords

References

  1. Zangaladze A, Nei M, Liporace JD, Sperling MR. Characteristics and clinical significance of subclinical seizures. Epilepsia. 2008;49(12):2016-2021. doi:10.1111/j.1528-1167.2008.01672.x
  2. Velkey A, Siegler Z, Janszky J, Duray B, Fogarasi A. Clinical value of subclinical seizures in children with focal epilepsy. Epilepsy Res. 2011;95(1-2):82-85. doi:10.1016/j.eplepsyres.2011.03.001
  3. Farooque P, Duckrow R. Subclinical seizures during intracranial EEG recording: are they clinically significant?. Epilepsy Res. 2014;108(10):1790-1796. doi:10.1016/j.eplepsyres.2014.09.020
  4. Fernández Torre JL, Hernández Hernández M, Martino J, Hinojo C. Subclinical focal seizures as a sign of progression in gliomas. Epileptic Disord. 2014;16(4):546-553. doi:10.1684/epd.2014.0701
  5. Vossel KA, Ranasinghe KG, Beagle AJ, et al. Incidence and impact of subclinical epileptiform activity in Alzheimer's disease. Ann Neurol. 2016;80(6):858-870. doi:10.1002/ana.24794
  6. Jin B, Wang S, Yang L, et al. Prevalence and predictors of subclinical seizures during scalp video-EEG monitoring in patients with epilepsy. Int J Neurosci. 2017;127(8):651-658. doi:10.1080/00207454.2016.1220946
  7. Anderson CT, Tcheng TK, Sun FT, Morrell MJ. Day-Night Patterns of Epileptiform Activity in 65 Patients With Long-Term Ambulatory Electrocorticography. J Clin Neurophysiol. 2015;32(5):406-412. doi:10.1097/WNP.0000000000000183
  8. Cox BC, Khattak JF, Starnes K, et al. Subclinical seizures on stereotactic EEG: characteristics and prognostic value. Seizure. 2022;101:96-102. doi:10.1016/j.seizure.2022.07.015

Details

Primary Language

English

Subjects

Neurology and Neuromuscular Diseases

Journal Section

Research Article

Early Pub Date

December 18, 2024

Publication Date

April 1, 2025

Submission Date

June 24, 2024

Acceptance Date

December 9, 2024

Published in Issue

Year 2025 Volume: 18 Number: 2

AMA
1.Erdoğan Ç, Akbudak İH, Apaydın Doğan E. Subclinical seizures on EEG with sleep phases and clinical significance in patients with focal epilepsy. Pam Med J. 2025;18(2):282-292. doi:10.31362/patd.1503792

Creative Commons Lisansı
Pamukkale Medical Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License